长非编码RNA B4GALT1-AS1 的下调与乳腺癌的发展有关
Samaneh Ahvaz1, Mohammad Amini1, Amirhossein Yari1,2
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Scientific reports
|February 7, 2024
概括
在乳腺癌 (BC) 中,长非编码RNA B4GALT1-AS1 的下调,影响患者的生存率. 需要进一步的研究来探索其与YAP在BC亚型中的相互作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 长非编码RNAs (lncRNAs) 与人类癌症的发展有关.
- 乳腺癌 (BC) 中 lncRNA B4GALT1-AS1 的特定作用尚不清楚.
研究的目的:
- 研究乳腺癌组织中lncRNA B4GALT1-AS1的表达.
- 分析B4GALT1-AS1与BC.中的基因表达和通路的相关性.
- 探索B4GALT1-AS1在BC进展和患者生存中的潜在作用.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库进行表达分析.
- 从28个配对的BC和边缘组织中提取RNA,用于定量实时PCR.
- 进行生物信息学分析以确定共同表达的基因和相关途径.
主要成果:
- 与相邻的正常组织相比,BC组织中的B4GALT1-AS1显著下调.
- TCGA数据证实了BC中B4GALT1-AS1的下调.
- 生物信息学分析确定GNAI1是高度相关的基因,并建议与Hippo路径组件YAP的联系.
结论:
- B4GALT1-AS1下调是乳腺癌的一个特征.
- 失去B4GALT1-AS1功能可能会导致BC患者的生存率低下.
- 需要对BC亚型中的B4GALT1-AS1-YAP相互作用进行进一步的研究.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


